At BeneCard PBF, we work with plans to build GLP1 strategies that reflect the realities of their populationnot onesizefitsall formulas
To ensure batch-to-batch consistency, efficacy, and safety of HMPs in accordance with WHO recommendations, quantitative evaluation of known bioactive markers is crucial, supported by integrated approaches like DNA barcoding, HPLCMS, and GCMS (Noviana et al
Ann Rheum Dis
Key biomarkers to monitor would include a comprehensive metabolic panel (CMP), a lipid panel (cholesterol, triglycerides), and especially liver function tests (ALT, AST, GGT)
Purpose-built for physicians Older, cost-effective anti-obesity medications maintain weight loss after GLP-1 therapy Key takeaways: Participants who switched to older anti-obesity drugs after GLP-1 therapy lost about 25% of their weight from baseline, researchers found
Its effects on hair are comparable to Minoxidil in som e studies, though more researc h is needed for advanced hair loss
